Introduction
One of the major concerns of society in health issues is diabetes. Malfunction in the metabolism of blood sugar (Glucose) leads to diabetes. This malfunction could be due to two disabilities: 1) insulin production or/and 2) disability of the body to respond to insulin, either of which results in the increase of blood sugar. This epidemic disease is rapidly increasing in number and is considered as one of the main global health problems. Approximately 230 million individuals are suffering from diabetes around the world, and it has been predicted that the number of diabetic people will rise to about 300 million by the year 2025 (1, 2) . Diabetes is divided into two types: type 1 is an insulin-dependent condition which is an autoimmune disease. Blood insulin level decreases due to damage to the pancreatic Beta cells which produce insulin by the attack of immune cells. Type 2 is an insulin-independent condition which is the result of resistance of the body to insulin. 90 to 95 percent of USA diabetic people are suffering from type 2 according to Wang et al. (3) . The common synthetic drugs for diabetes are not popular because of the side effects, difficult regimen and high expenses, so the number of patients who tend to use folk treatments, especially medicinal plants, are increasing (4, 5) . According to the World Health Organization (WHO) more researches are needed in the field of herbal treatment for diabetes (6) .
Cynodon dactylon (C.d) is a member of the Poaceae family grown in Asia, Europe, Australia and Africa, and is also known as Bermuda grass. There are some reports indicating its medicinal potential. Antiviral, anti microbial, healing effects on urinary tract infection, syphilis, dysentery and prostatitis are being discussed in some reports (7). Kumar Singh et al. (7) reported an interesting impact of C.d on blood glucose level contributing to its antidiabetic and hypoglycemic activity. The main constituents of C.d are Glycerin, 9, 12-Octadecadienoyl chloride, Hexadecanoic acid which indicate its medicinal potential (8) .
Electromagnetic field (EMF) has been proved to be therapeutically effective in a wide range of medical conditions. Antimicrobial, wound healing and neurological disorders are just some examples of this usage. Recently, some researches have been shown that indicate the anti diabetic and hypoglycemic effect of EMF. Tomonori Sakurai et al. (9) reported that a low frequency magnetic field increases the insulin se-cretion level from beta cells. Öcal et al. (10) reported the decrease of blood glucose level in the presence of an alternating magnetic field.
The present study was conducted to evaluate the influence of Cynodon dactylon, and magnetic field separately and a combination of them along with insulin. The determination of these effects has been studied on the diabetic mouse.
Material and Methods

Treatment groups
After obtaining the approval decision of law and bioethics committee of the Veterinary collage of Urmia University regarding the experiment, a total of 96 mice (Wistar strain) were subjected to the study in 12 groups, 8 mice for each group. The weights of mice were between 142 to 207 gram with the average weight of 175±2 gr. The first group was considered as control group and received nothing,the second group was the scheme group and received normal saline. The third and fourth groups were treated with 50 mgr/Kg of C.d extract, and the glucose levels in the third group were measured 5 minutes after administration while in the fourth group measurements were taken 60 minutes after injection. The reason for separating these two groups is prohibiting any increase of blood glucose because of stress due to secretion of adrenalin in the first blood collection from the tail vein. The fifth and 6 th groups received 100 mgr/Kg of C.d extract and the glucose level in the fifth group were measured 5 minutes after administration of C.d and in the 6 th group it was measured 60 minutes after C.d administration. The 7 th group was injected by 0.5 μL/Kg insulin. The 8 th group was treated by insulin plus a first dose of the plant. The 9 th group was subjected to EMF treatment by a frequency of 110 KHz and 700±20 mG. The 10 th group was treated by insulin injection and EMF exposure. The 11 th group was treated by a first dose of the plant and EMF exposure. Lastly, the 12 th group was subjected to the treatment by the three items: insulin, C.d and EMF. All the injections were intraperinoteal. Then animals were placed in separate cages in standard conditions at 22±2°C with a 12 light-dark cycle in which they had free access to pellet food and tap water during the experiment in the animal lab of the veterinary college of Urmia University.
Induction of diabetes
After adaptation of the mice to the environment, they had 24 hours fast. Then they were anesthetized by a combination of ketamine hydrochloride and xylazine hydrochloride. 60 mg/ Kg ketamine mixed with 10 mg/Kg xylazine and injected into all groups except the control group. The purpose of this combination was inducing diabetes in the mice rather than anesthesia. This mixture induces a sustained hyperglycemia Kawai et al. (11) , Eun-Joo Park et al. (12) . Their blood glucose levels were measured when they were anesthetized.
Extract of C.d
The root and stem of Cynodon dactylon were powdered and soaked in 70% ethyl alcohol (Mrec Co) and 30% water for 48 hours in 24°c, then filtered by Watman paper. Then the extracts were obtained from a rotator device. The extracts were frozen and used as 100% alcoholic extract. Using normal saline, 0.5% extracts were prepared.
Electromagnetic Field Application
The EMF was generated by a DC power supply signal generator (made in PHYWE German). The generators generated a 2 phase square wave. The frequency was measured by a digital teslameter from a distance of 7.5 cm from the generator, and it was of 700±20 mG intensity and frequency of 110 KHz. In order to restrain the mice during the exposure time, a 30×25×20 fiber box was made with no nails. Two 2×2 windows were placed in its wall. The mice were exposed to the EMF for 30 minutes one time.
Blood sample collection After 5 minutes and then 60 minutes from the injection of C.d, blood samples were collected in order to screen the glucose level. Blood of the other groups were collected after 5 minutes of application of ketamine and xylazine, insulin or EMF. For that purpose blood was drawn from the rats' tail vein. Then, samples were analyzed for blood glucose levels by the glucometer apparatus to gather data. The glucometer apparatus was made in Germany from the Converjent (Elegance brand) factory.
Statistical analysis
The data were collected and analyzed by the variance method (ANOVA) and the significance range was considered as p<0.05. The groups which had significant differences were compared by Tukey and Bonferroni tests in order to compare the means. All of the analyses were carried out by SPSS package (Version 18).
Results
The results of the study are shown in Table 1 . After induction of hyperglycemia by ketamine and xylazine, blood glucose levels were high in all groups, which generally is considered as Diabetic. The second group received normal saline and it did not have any effect on glucose levels after hyperglycemia induction. Blood glucose levels were measured after 5 minutes of C.d administration. The dose of 50 mg/Kg of C.d decreased the glucose level significantly. The blood glucose level dropped to the normal range, which is seen in the first group. The influence of the first dose of C.d after 5 minutes and insulin showed no significant difference on blood glucose level. The second dose (100 mg/Kg) lowered the glucose level significantly after 5 minutes, also. Although it affected the glucose level like insulin with no meaningful difference, it also had no significant difference with the second group which was diabetic. One hour after administering C.d, blood glucose levels were measured in other groups. The first dose maintained its effect. It did not have any significant differences with the control and insulin administrated groups, while there were significant differences between first dose after one hour and second group. The second dose lowered glucose level after one hour more than what it had after 5 minutes. The dif-ference was not significant, but its effect after one hour was significantly different from the second group, while we did not see this difference in the first 5 minutes. The mixture effect of first dose of C.d and insulin was significant and it reduced the blood glucose level meaningfully. However, the mixture did not have a double effect, the mean level was significantly higher than the solely insulin and C.d administrated groups.
The EMF application significantly reduced the blood glucose level of mice. The EMF at this frequency lowered the glucose compared to the second group, but their glucose levels were still higher than the control and insulin injected groups. According to the data, the enhancer effect of EMF at this frequency was contemplated, so the combination of items were observed. The administration of insulin in the presence of EMF was significant, it reduced the blood glucose level to the normal range. The mean glucose levels of this group were lower than the control group. The point was that the blood glucose level in this group was significantly lower than the insulin only injected group.
The administration of C.d was also investigated in the presence of EMF. This combination also decreased the glucose level significantly. It was not as effective as the insulin or C.d injection solely. It seems that EMF reduces the effect of C.d or Insulin when they are injected alone. In contrast, C.d did not have any enhancing effect on the influence of EMF, since there was no significant difference between the EMF applied group and this group.
In the final treatment, C.d injection was accompanied by insulin administrated in the presence of EMF. This combination decreased the glucose level to the normal level as there were no differences in the glucose level. The mean results of the three mixture administration were lower than the mean results of C.d injected group and the group of insulin, without significant differences.
Discussion
According to data in the present study, C.d has a very effective influence on blood glucose level. C.d can decrease the blood glucose level in diabetic mice to the normal level. There are several studies indicating the same results, that C.d has antihyperglycemic effects on mice when it was used for diabetes treatment in folk medicine (13) . Kumar Singh et al. (7) studied the ethanolic extract of C.d in normal and streptozotocin-induced diabetic rats in three doses of 250, 500 and 750 mg/Kg by oral administration. They found that all the dosages have a significant effect in reducing glucose level. The most effective dosage was 500 mg/Kg, which dropped glucose level by 42.12% for normal mice and 43.42% for diabetic mice. In this study, the most effective dose was 50 mg/Kg, with a sustained effect. The difference in the dosage effects could be due to different administrations, oral and IP injection. Some of the bioactive substances in C.d can be broken down through the digestive system in oral administration and as a result higher dosages are needed for more effect. The fact that some plants have more antihyperglycemic effects in lower dosage than the higher one is a common phenomenon in herbal nature. For instance C.d in the mentioned and present study, Peganum Harmala Mohammad Nezhady et al. (14) and Vinca rosea Chattopadhyay et al. (15) . In an another study, Jarald et al. (16) investigated polysaccharide and non-polysaccharide fractions of an aqueous extract of C.d on glucose overloaded and alloxan-induced diabetic rats by oral administration. They found that 400 mg/Kg of non-polysaccharide fractions have a significant effect on blood glucose levels. Also, they studied the insulin level, which did not increase during the C.d administration. This fact indicates that C.d does not have a secondary effect and it does not affect glucose level by increasing the insulin level. It seems that C.d has an insulin-like effect in reducing blood glucose level. By the aforementioned studies and that found in the present study, it can be concluded that C.d has a meaningful reducing effect on glucose level and it can be considered as an alternative medication for diabetes mellitus.
There are many evidences supporting the hypoglycemic ability of magnetic field exposure, but the optimum frequency and exposure time remain unclear (17) (18) (19) (20) (21) . Öcal et al. (10) investigated the effect of 5mT and 8mT on healthy and diabetic rats for the duration of 165 minutes for three weeks. They found that alternating magnetic field decreases the blood glucose level in both healthy and diabetic rats. Eghdami et al. (19) reported that the blood glucose level of mice, who were subjected to a field of 25 Hz and intensity of 250 μT for 45 minutes for 2 weeks, is decreased more efficienlyt than with metphormine and insulin. Sieroń et al. (4) 3 H uptake in organs and tissues of rat in the exposure to an extremely low electromagnetic field. They subjected the rats to the electromagnetic field with frequency of 10 Hz and intensity of 1.8-3.8 mT for one hour in 14 days. The results of radioactivity of [ 3 H] glucose showed that glucose uptake was significantly higher in the liver, kidney, heart muscle, cartilage, connective tissue, skin and tendon compared to the control group. They suggested that Extremely Low EMF (ELEMF) can facilitate transportation of glucose through the cell membrane. Sakurai et al. (9) worked on hamster-derived insulin secreting cells (TIH-T15) to investigate the effect of EL-EMF on them. The cells were exposed to an ELEMF freq with a frequency of 60 Hz and intensity of 5mT. Cell numbers were increased during 5 days of exposure in the absence of glucose, while the exposure for 5 days in the presence of 100 mg/ dL glucose and for 2 days in the absence of glucose, increased the insulin secretion. Also they found that ELEMF increased the concentration of intracellular insulin in the cell lines.
Conclusion
According to the results of this study, it could be concluded that Cynodon dactylon can be considered as a good alternative medication for diabetes mellitus, also EMF has an impact on the blood glucose level of diabetic mice. For determination of an optimum dosage of C.d and frequency and exposure duration of EMF further studies are required.
